We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Model Enables Personalized Glucose Predictions for Type 1 Diabetes

By LabMedica International staff writers
Posted on 18 Mar 2026

Type 1 diabetes (T1D) requires careful blood glucose monitoring and precise insulin dosing, as even small errors can lead to dangerous excursions. More...

Continuous glucose monitoring (CGM) provides real-time data for prediction, but physiologic differences between users and limited adaptability for new users remain challenges. Many existing algorithms focus on either short- or long-term patterns, overlooking complementary dynamics and reducing consistency across ages and daily routines. Researchers have now developed a machine-learning model to improve individual glucose forecasting by addressing the patient-to-patient variability that has limited current tools.

Developed at Jeonbuk National University (Jeonju, South Korea), BiT‑MAML combines bidirectional long short‑term memory (LSTM) and Transformer architectures with Model‑Agnostic Meta‑Learning (MAML). The LSTM component processes continuous glucose time series bidirectionally to capture short‑term fluctuations. The Transformer, utilizing a multi‑head attention, models longer‑range, lifestyle‑linked cycles, while meta‑learning accelerates personalization from limited data.

Performance was assessed using leave‑one‑patient‑out cross‑validation, training on multiple patients and testing on an unseen case. Compared with conventional approaches, the model achieved significantly lower prediction errors. Absolute errors ranged from 19.64 to 30.57 milligrams per deciliter across individuals, highlighting gains over standard long short‑term memory baselines and persistent variability.

The work was published in Scientific Reports. The researchers emphasize the importance of evaluation frameworks that transparently capture variability across users. They note that combining advanced architectures with robust assessment can strengthen trust and performance in continuous glucose monitoring–based prediction for people with type 1 diabetes.

"BG dynamics are not uniform across all patients. The physiological patterns of an elderly patient are vastly different from those of a young adult," said Jaehyuk Cho, Professor in the Department of Software Engineering at Jeonbuk National University. "Addressing this challenge will contribute to the development of effective CGM models that can serve diverse patients with T1D, from children to the elderly."


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.